"Hours may differ due to Coronavirus response. Featuring 361 private patient beds, West Penn Hospital has served Bloomfield and its surrounding communities since 1848. With an outstanding reputation for clinical care, excellence in nursing and exemplary patient outcomes, West Penn Hospital offers specialized services that draw patients throughout the tri-state area."

During the past decade, Western Pennsylvania Hospital conducted 95 clinical trials. In the 10-year time frame, 95 clinical trials started and 83 clinical trials were completed, i.e. on average, 87.4% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 38 clinical trials were completed. i.e. 86.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Western Pennsylvania Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 53 trials, followed by "National Cancer Institute (NCI)" with 46 trials sponsored, "Radiation Therapy Oncology Group" with 42 trials sponsored, "SWOG Cancer Research Network" with 14 trials sponsored and "NSABP Foundation Inc" with 14 trials sponsored. Other sponsors include 130 different institutions and companies that sponsored additional 87 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Western Pennsylvania Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 146 trials as a collaborator, "NRG Oncology" with 24 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator, "Eastern Cooperative Oncology Group" with 8 trials as a collaborator and "Cancer and Leukemia Group B" with 6 trials as a collaborator. Other collaborators include 99 different institutions and companies that were collaborators in the rest 71 trials.

According to Clinical.Site data, the most researched conditions in "Western Pennsylvania Hospital" are "Breast Cancer" (17 trials), "Lung Cancer" (16 trials), "Lymphoma" (16 trials), "Leukemia" (15 trials) and "Colorectal Cancer" (12 trials). Many other conditions were trialed in "Western Pennsylvania Hospital" in a lesser frequency.

Most popular intervention types in "Western Pennsylvania Hospital" are "Drug" (222 trials), "Other" (90 trials), "Biological" (78 trials), "Procedure" (68 trials) and "Radiation" (67 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (43 trials), "Laboratory Biomarker Analysis" (37 trials), "Quality-of-Life Assessment" (37 trials), "Paclitaxel" (31 trials) and "Carboplatin" (23 trials). Other intervention names were less common.

The vast majority of trials in "Western Pennsylvania Hospital" are 209 trials for "All" genders, 77 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Western Pennsylvania Hospital". 1 are not yet recruiting, 38 are recruiting, 61 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 166 completed trials in Western Pennsylvania Hospital, 1 suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in Western Pennsylvania Hospital, 23 "Phase 1" clinical trials were conducted, 113 "Phase 2" clinical trials and 146 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 21 trials that are defined as “Not Applicable".

Western Pennsylvania Hospital has several departments that took part in Clinical trials: "Western Pennsylvania Cancer Institute" - 27 trials